Hematology & Oncology in Chicago, IL
187 verified hematology & oncology doctors in Chicago. Page 2 of 4.
Hematologist-oncologists treat blood disorders and cancers, coordinating chemotherapy and blood-related care.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the Illinois Dept. of Financial & Professional Regulation
Dr. Rita Nanda, MD
Hematology & Oncology
CMS Open Payments· $472,507 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$472,507
Total received
80
Transactions
9
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 96% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Rita Nanda do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Olatoyosi Odenike, MD
Hematology & Oncology
CMS Open Payments· $557,344 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$557,344
Total received
52
Transactions
7
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 97% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Olatoyosi Odenike do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Christopher Daugherty, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Richard Larson, MD
Hematology & Oncology
CMS Open Payments· $42,102 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$42,102
Total received
18
Transactions
4
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 86th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Richard Larson do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Olufunmilayo Olopade, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Gini Fleming, MD
Hematology & Oncology
CMS Open Payments· $373,098 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$373,098
Total received
15
Transactions
8
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 95% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Gini Fleming do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Deepti Singh, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Thomas Gajewski, MD
Hematology & Oncology
CMS Open Payments· $1,928,915 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,928,915
Total received
41
Transactions
5
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 99% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Thomas Gajewski do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Philip Hoffman, MD
Hematology & Oncology
CMS Open Payments· $19,560 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$19,560
Total received
3
Transactions
3
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 83th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Philip Hoffman do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Mark Ratain, MD
Hematology & Oncology
CMS Open Payments· $19,750 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$19,750
Total received
2
Transactions
1
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 83th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Mark Ratain do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Everett Vokes, MD
Hematology & Oncology
CMS Open Payments· $127,339 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$127,339
Total received
6
Transactions
3
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 91% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Everett Vokes do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Lucy Godley, MD
Hematology & Oncology
CMS Open Payments· $63.71 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$63.71
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is on the lower end — around the 45th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Lucy Godley do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Wendy Stock, MD
Hematology & Oncology
CMS Open Payments· $870,577 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$870,577
Total received
14
Transactions
5
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 98% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Wendy Stock do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Damiano Rondelli, MD
Hematology & Oncology
CMS Open Payments· $3,958 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$3,958
Total received
8
Transactions
4
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 77th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Damiano Rondelli do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Evelyn Currie, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Sarika Jain, MD
Hematology & Oncology
CMS Open Payments· $113.91 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$113.91
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is on the lower end — around the 49th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Sarika Jain do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Olwen Hahn, MD
Hematology & Oncology
CMS Open Payments· $38,954 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$38,954
Total received
35
Transactions
4
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 86th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Olwen Hahn do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Justin Kline, MD
Hematology & Oncology
CMS Open Payments· $1,325,511 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,325,511
Total received
27
Transactions
5
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 99% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Justin Kline do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Sonali Smith, MD
Hematology & Oncology
CMS Open Payments· $89,952 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$89,952
Total received
16
Transactions
7
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 90% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Sonali Smith do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Kaoutar Tlemcani, MD
Hematology & Oncology
CMS Open Payments· $440.25 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$440.25
Total received
8
Transactions
6
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 60th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Kaoutar Tlemcani do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Leonardo Faoro, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Jessica Altman, MD
Hematology & Oncology
CMS Open Payments· $541,430 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$541,430
Total received
46
Transactions
11
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 97% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Jessica Altman do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Sangeetha Nimmagadda, MD
Hematology & Oncology
CMS Open Payments· $850.68 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$850.68
Total received
31
Transactions
16
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 65th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Sangeetha Nimmagadda do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Juan Restrepo, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Jaya Sharma, MD
Hematology & Oncology
CMS Open Payments· $5,357 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$5,357
Total received
35
Transactions
19
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 78th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Jaya Sharma do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Carlos Vigil, MD
Hematology & Oncology
CMS Open Payments· $48.00 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$48.00
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is on the lower end — around the 44th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Carlos Vigil do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Shuo Ma, MD
Hematology & Oncology
CMS Open Payments· $6,145,094 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$6,145,094
Total received
133
Transactions
15
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 100% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Shuo Ma do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Oana Danciu, MD
Hematology & Oncology
CMS Open Payments· $3,850,677 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$3,850,677
Total received
45
Transactions
9
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 100% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Oana Danciu do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Solomon Adler, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Kehinde Adekola, MD
Hematology & Oncology
CMS Open Payments· $77,471 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$77,471
Total received
5
Transactions
2
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 89th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Kehinde Adekola do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Michael Thirman, MD
Hematology & Oncology
CMS Open Payments· $199,380 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$199,380
Total received
14
Transactions
4
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 93% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Michael Thirman do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Satyajit Kosuri, MD
Hematology & Oncology
CMS Open Payments· $84,964 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$84,964
Total received
12
Transactions
3
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 90% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Satyajit Kosuri do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Kenneth Carson, MD
Hematology & Oncology
CMS Open Payments· $93.58 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$93.58
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is on the lower end — around the 47th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Kenneth Carson do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Halla Nimeiri, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Cara Rosenbaum, MD
Hematology & Oncology
CMS Open Payments· $148,625 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$148,625
Total received
23
Transactions
8
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 92% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Cara Rosenbaum do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Shikha Jain, MD
Hematology & Oncology
CMS Open Payments· $23,086 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$23,086
Total received
11
Transactions
7
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 84th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Shikha Jain do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Seth Pollack, MD
Hematology & Oncology
CMS Open Payments· $310,218 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$310,218
Total received
19
Transactions
6
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 95% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Seth Pollack do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Fotios Asimakopoulos, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Bety Ciobanu, MD
Hematology & Oncology
CMS Open Payments· $8,239 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$8,239
Total received
183
Transactions
53
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 80th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Bety Ciobanu do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Sunita Nathan, MD
Hematology & Oncology
CMS Open Payments· $19,707 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$19,707
Total received
7
Transactions
3
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 83th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Sunita Nathan do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Young Kwang Chae, MD
Hematology & Oncology
CMS Open Payments· $131,556 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$131,556
Total received
99
Transactions
21
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 92% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Young Kwang Chae do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Helen Gharwan, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Lucy Chen, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Russell Szmulewitz, MD
Hematology & Oncology
CMS Open Payments· $2,967,102 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$2,967,102
Total received
63
Transactions
8
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 100% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Russell Szmulewitz do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Soonmo Kang, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Tabraiz Mohammed, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Manik Amin, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Maria Matsangou, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Jonas De Souza, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Murtuza Rampurwala, MD
Hematology & Oncology
CMS Open Payments· $2,553 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$2,553
Total received
2
Transactions
1
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 73th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Murtuza Rampurwala do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Smita Joshi, MD
Hematology & Oncology
CMS Open Payments· $245.75 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$245.75
Total received
2
Transactions
1
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 55th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Smita Joshi do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Aparna Kalyan, MD
Hematology & Oncology
CMS Open Payments· $922,461 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$922,461
Total received
31
Transactions
6
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 98% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Aparna Kalyan do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Shivi Jain, MD
Hematology & Oncology
CMS Open Payments· $83,206 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$83,206
Total received
15
Transactions
4
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 90% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Shivi Jain do not imply any wrongdoing. Many are meals, education, or research support.
Dr. April Swoboda, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Randy Sweis, MD
Hematology & Oncology
CMS Open Payments· $605,716 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$605,716
Total received
87
Transactions
14
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 97% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Randy Sweis do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Shamail Butt, MD
Hematology & Oncology
CMS Open Payments· $252.17 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$252.17
Total received
6
Transactions
5
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 56th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Shamail Butt do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Peter Riedell, MD
Hematology & Oncology
CMS Open Payments· $379,770 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$379,770
Total received
73
Transactions
10
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 95% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Peter Riedell do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Michael Bishop, MD
Hematology & Oncology
CMS Open Payments· $222,149 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$222,149
Total received
149
Transactions
12
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 94% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Michael Bishop do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Karan Dixit, MD
Hematology & Oncology
CMS Open Payments· $111,558 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$111,558
Total received
3
Transactions
3
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 91% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Karan Dixit do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Mylene Remo, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.